MarketCapExport financials
Heartland Express (HTLD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Heartland Express Financial Ratios 2025-2007 | HTLD
Brief overview of Heartland Express's multiples and efficiency
The review covers five available annual periods spanning 2019 to 2023.
Market valuation is represented by P/E 69.09x (median 21.46x), EV/EBITDA 6.42x (median 4.56x), P/S 0.83x (median 0.87x). Ratios sit near their own comparison base, with an average deviation of +13.7% from five-year medians.
Earnings yield calculated as 1/P/E is about 1.4%, showing current profit per unit of share price.
The latest available business-quality ratios are ROE -6.9%, ROA -4.4%, ROCE -5.3%. Losses and negative capital returns make ordinary P/E-like references unstable or inapplicable.
On PEG (1.89x), valuation is stretched relative to growth and requires strong execution.
The cash conversion cycle is 37.5 days versus 32.6 days initially. Turnover changed little.
Overall picture
Heartland Express's valuation and business quality look relatively balanced, with no pronounced distortion in either direction.
Annual Financial Ratios Heartland Express
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.8 | -30.5 | 69.1 | 9.7 | 15.0 | 21.5 | 21.5 | 23.1 | 25.0 | 30.4 | 20.4 | 26.6 | 25.7 | 19.2 | 19.0 | 22.0 | 25.9 | 20.8 | - | |
P/S |
0.8 | 0.9 | 0.8 | 1.3 | 2.0 | 2.4 | 2.6 | 2.8 | 3.1 | 2.8 | 2.0 | 2.6 | 3.1 | 2.2 | 2.5 | 2.7 | 3.2 | 2.3 | - |
EPS |
-0.7 | -0.4 | 0.2 | 1.7 | 1 | 0.9 | 0.9 | 0.9 | 0.9 | 0.7 | 0.8 | 1.0 | 0.8 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | - |
EV (Enterprise Value) |
654 M | 893 M | 993 M | 1.24 B | 1.03 B | 1.41 B | 1.7 B | 1.71 B | 2.02 B | 1.82 B | 1.72 B | 2.52 B | 2.13 B | 1.24 B | 1.38 B | 1.25 B | 1.42 B | 1.4 B | -7.96 M |
EBITDA per Share |
1.31 | 2.05 | 3.06 | 4.07 | 2.63 | 2.5 | 2 | 2.02 | 1.69 | 2.18 | 2.22 | 2.37 | 1.74 | 1.6 | 1.83 | 1.69 | 1.51 | 1.5 | - |
EV/EBITDA |
6.4 | 5.5 | 4.1 | 3.9 | 4.9 | 6.9 | 9.1 | 9.2 | 12.8 | 8.7 | 7.5 | 10.9 | 12.6 | 7.7 | 7.3 | 8.1 | 10.3 | 9.7 | - |
PEG |
1.89 | -5.6 | 5.82 | 0.47 | 2.88 | 5.62 | 24.21 | -10.33 | 0.75 | -1.56 | -1.52 | 1.55 | 1.71 | -2.49 | 1.46 | - | - | - | - |
P/B |
0.6 | 0.7 | 0.7 | 0.8 | 1.3 | 1.6 | 2.3 | 2.7 | 3.3 | 3.4 | 3.2 | 4.7 | 4.6 | 4.1 | 3.9 | 2.7 | 2.7 | - | - |
P/CF |
7.5 | 6.3 | 6.2 | 6.6 | 9.6 | 8.5 | -89.9 | -74.0 | -25.2 | 24.6 | -55.7 | -69.3 | -75.8 | 33.4 | -49.0 | 13.9 | 14.6 | 12.0 | - |
ROE % |
-6.94 | -3.61 | 1.71 | 15.62 | 10.90 | 9.78 | 10.66 | 11.80 | 13.08 | 11.15 | 15.55 | 17.80 | 17.75 | 21.19 | 20.52 | 18.62 | 15.49 | 19.43 | - |
ROA % |
-4.40 | -2.23 | 0.98 | 8.00 | 8.54 | 7.44 | 8.12 | 9.01 | 9.53 | 7.64 | 9.93 | 11.16 | 9.74 | 13.16 | 13.30 | 12.29 | 10.33 | - | - |
ROCE % |
-5.31 | -1.67 | 3.06 | 12.45 | 12.30 | 10.61 | 7.53 | 8.74 | 5.17 | 11.35 | 12.17 | 14.21 | 12.42 | 18.89 | 22.20 | 20.00 | 15.66 | 27.20 | - |
Current Ratio |
- | - | - | - | - | - | 2.4 | 3.6 | 2.3 | 3.1 | 2.1 | 2.2 | 1.6 | 4.2 | 4.7 | - | - | - | - |
DSO |
37.6 | 33.9 | 36.7 | 36.3 | 32.6 | 31.8 | 34.9 | 29.4 | 42.5 | 30.7 | 34.0 | 40.6 | 56.5 | 32.7 | 30.7 | 28.9 | 14.8 | - | - |
DPO |
- | - | - | - | - | 21.5 | 8.3 | 7.7 | 10.1 | 9.1 | 4.6 | 4.2 | 21.1 | 6.4 | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 34.9 | 29.4 | 42.5 | 30.7 | 34.0 | 40.6 | 56.5 | 32.7 | 30.7 | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 26.7 | 21.7 | 32.4 | 21.6 | 29.4 | 36.4 | 35.4 | 26.3 | 30.7 | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Heartland Express
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.01 | 0.14 | -0.06 | -0.25000000000000006 | -0.11 | -0.14 | -0.18 | -0.030000000000000027 | -0.12 | -0.04 | -0.19 | 0.07 | -0.14 | 0.1 | 0.16 | 0.18999999999999995 | 0.31 | 0.97 | 0.21 | 0.26 | 0.31 | 0.26 | 0.17 | 0.21999999999999997 | 0.25 | 0.24 | 0.16 | 0.16000000000000003 | 0.25 | 0.27 | 0.21 | 0.27 | 0.23 | 0.22 | 0.16 | 0.45 | 0.1 | 0.18 | 0.17 | 0.16 | 0.15 | 0.2 | 0.17 | 0.2 | 0.17 | 0.27 | 0.2 | 0.25 | 0.26 | 0.3 | 0.16 | 0.18 | 0.19 | 0.23 | 0.23 | 0.17 | 0.15 | 0.21 | 0.19 | 0.2 | 0.17 | 0.25 | 0.16 | 0.17 | 0.2 | 0.18 |
EBITDA per Share |
0.05 | 0.23 | -0.03 | 147 | -0.08 | -0.14 | -0.17 | -27.4 | -0.07 | 0.02 | -0.17 | 1.72 K | -0.08 | 0.22 | 0.31 | 3.46 K | 0.45 | 1.34 | 0.29 | -122 | 0.43 | 0.35 | 0.24 | -172 | 0.34 | 0.31 | 0.22 | 1.23 K | 0.33 | 0.36 | 0.26 | -198 | 0.31 | 0.28 | 0.16 | 5.48 K | 0.17 | 0.26 | 0.24 | -5.36 K | 0.25 | 0.3 | 0.25 | -41 | 0.29 | 0.41 | 0.33 | 3.17 K | 0.42 | 0.47 | 0.24 | 0.31 | 0.48 | 0.55 | 0.53 | -134 | 0.4 | 0.47 | 0.44 | -51.1 | 0.44 | 0.51 | 0.38 | - | 0.49 | 0.41 |
ROE % |
-1.69 | -2.89 | -5.67 | -6.74 | -4.39 | -4.45 | -3.48 | -3.55 | -2.73 | -2.85 | -1.54 | 1.69 | 2.91 | 7.06 | 15.57 | 16.38 | 17.36 | 17.91 | 11.30 | 10.95 | 10.59 | 10.01 | 9.94 | 9.97 | 9.40 | 9.58 | 10.27 | 11.08 | 12.85 | 13.01 | 12.65 | 12.19 | 15.27 | 13.54 | 13.23 | 13.65 | 9.52 | 10.59 | 11.22 | 11.58 | 12.61 | 13.14 | 14.29 | 14.79 | 15.69 | 17.61 | 19.16 | 19.02 | 18.48 | 18.14 | 17.91 | 20.87 | 21.81 | 20.51 | 19.57 | 17.83 | 17.94 | 18.97 | 20.18 | 19.81 | 19.39 | 20.72 | 18.84 | 4.60 | 5.71 | 4.24 |
ROA % |
-1.05 | -1.80 | -3.53 | -4.16 | -2.66 | -2.69 | -2.10 | -2.11 | -1.63 | -1.63 | -0.90 | 0.93 | 1.52 | 3.63 | 10.05 | 11.04 | 12.30 | 13.42 | 8.68 | 8.36 | 8.03 | 7.63 | 7.52 | 7.53 | 7.09 | 7.09 | 7.63 | 8.26 | 9.62 | 9.81 | 9.47 | 9.02 | 11.13 | 9.78 | 9.46 | 9.70 | 6.58 | 7.28 | 7.54 | 7.65 | 8.18 | 8.46 | 9.24 | 9.52 | 10.04 | 11.10 | 11.64 | 11.33 | 10.68 | 10.61 | 10.85 | 12.74 | 13.61 | 12.93 | 12.47 | 11.65 | 11.85 | 12.40 | 13.16 | 12.93 | 12.71 | 12.96 | 11.81 | 3.04 | 3.07 | 2.92 |
ROCE % |
-0.61 | -1.49 | -4.13 | -5.08 | -2.88 | -2.83 | -1.73 | -1.56 | -0.87 | -0.81 | 0.29 | 2.93 | 3.89 | 6.66 | 16.19 | 17.20 | 18.57 | 20.27 | 12.73 | 12.27 | 11.88 | 11.04 | 10.84 | 10.79 | 10.20 | 10.18 | 10.98 | 11.67 | 13.54 | 13.87 | 13.25 | 12.30 | 9.69 | 8.10 | 8.11 | 9.17 | 10.90 | 12.05 | 12.67 | 12.92 | 13.96 | 14.61 | 15.97 | 16.98 | 17.80 | 19.72 | 20.92 | 20.04 | 19.29 | 19.24 | 19.34 | 22.91 | 24.56 | 22.98 | 21.95 | 19.98 | 19.73 | 20.95 | 22.18 | 21.95 | 21.72 | 23.07 | 20.75 | 5.36 | 6.52 | 4.24 |
DSO |
518.2 | 469.9 | 441.8 | 502.4 | 560.0 | 560.8 | 538.9 | 450.7 | 518.1 | 494.7 | 478.2 | 428.0 | 465.2 | 444.5 | 493.3 | 504.3 | 752.0 | 1669.0 | 1631.0 | 1814.4 | 1991.1 | 1953.0 | 1709.4 | 34.6 | 1605.4 | 1704.0 | 1559.1 | 32.0 | 1489.8 | 1806.8 | 1665.9 | 32.4 | 1625.4 | 1521.5 | 1335.5 | 37.2 | 488.6 | 31.7 | 32.7 | 32.1 | 33.2 | 32.8 | 33.5 | 32.8 | 33.7 | 34.3 | 36.7 | 36.9 | 36.9 | 36.1 | 35.7 | 33.0 | 34.1 | 34.5 | 33.4 | 32.6 | 34.0 | 32.6 | 31.9 | 30.8 | 31.4 | 31.1 | 31.5 | 30.6 | 31.5 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.1 | 23.8 | - | - | - | - | - | - | - | 22.5 | 33.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Heartland Express, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
Bermuda
Canada
Britain
China
Mexico
Cayman-islands
Jersey